Maximizing benefit of radiopharmaceuticals in the systemic treatment of prostate cancer

Research output: ThesisResearch VU University Amsterdam, graduation VU University AmsterdamAcademic

Original languageEnglish
QualificationDoctor of Philosophy
Awarding Institution
  • VU Vrije Universiteit
Supervisors/Advisors
  • Verheul, Henk, Supervisor
  • Bloemendal, Haiko J., Co-supervisor, External person
  • van den Eertwegh, Alfons, Co-supervisor
  • de Klerk, John M. H., Co-supervisor, External person
Award date31 Jan 2017
Publication statusPublished - 2017

Cite this

@phdthesis{de54742d7c004b949759b6ee4ac8fd3c,
title = "Maximizing benefit of radiopharmaceuticals in the systemic treatment of prostate cancer",
keywords = "Prostate cancer, Radiopharmaceuticals, Docetaxel",
author = "{van Dodewaard-de Jong}, JM",
year = "2017",
language = "English",
school = "VU Vrije Universiteit",

}

Maximizing benefit of radiopharmaceuticals in the systemic treatment of prostate cancer. / van Dodewaard-de Jong, JM.

2017. 211 p.

Research output: ThesisResearch VU University Amsterdam, graduation VU University AmsterdamAcademic

TY - THES

T1 - Maximizing benefit of radiopharmaceuticals in the systemic treatment of prostate cancer

AU - van Dodewaard-de Jong, JM

PY - 2017

Y1 - 2017

KW - Prostate cancer

KW - Radiopharmaceuticals

KW - Docetaxel

M3 - Research VU University Amsterdam, graduation VU University Amsterdam

ER -